SFCM
MDGL icon

Seven Fleet Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Seven Fleet Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Buy
4,973
+1,580
+47% +$809K 0.44% 37
2026
Q1 		$1.78M Buy
3,393
+1,533
+82% +$732K 0.56% 42
2025
Q4 		$1.08M Buy
+1,860
New +$950K 0.73% 26

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Seven Fleet Capital Management's MDGL Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Madrigal Pharmaceuticals (MDGL) stake by 47% in Q2 2026, buying an estimated $809K and bringing the position to 4,973 shares worth $2.67M. The position accounts for 0.44% of the portfolio, ranked #37.

Seven Fleet Capital Management first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Seven Fleet Capital Management held 4,973 shares of Madrigal Pharmaceuticals worth $2.67M as of Q2 2026.
  • Seven Fleet Capital Management bought 1,580 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $809K.
  • Madrigal Pharmaceuticals made up 0.44% of Seven Fleet Capital Management's portfolio in Q2 2026, its #37 holding.
  • Seven Fleet Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.